AUD 0.03
(-10.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 12.21 Million AUD | 130.06% |
2023 | 5.3 Million AUD | 162.43% |
2022 | 2.02 Million AUD | -59.59% |
2021 | 5 Million AUD | 6095.02% |
2020 | 80.8 Thousand AUD | -87.62% |
2019 | 652.74 Thousand AUD | -85.83% |
2018 | 4.6 Million AUD | -6.98% |
2017 | 4.95 Million AUD | -67.79% |
2016 | 15.37 Million AUD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 5.07 Million AUD | 0.0% |
2024 FY | 12.21 Million AUD | 130.06% |
2024 Q4 | 12.21 Million AUD | 0.0% |
2023 Q4 | 5.3 Million AUD | 0.0% |
2023 FY | 5.3 Million AUD | 162.43% |
2023 Q2 | 8.91 Million AUD | 0.0% |
2022 Q4 | 2.02 Million AUD | 0.0% |
2022 FY | 2.02 Million AUD | -59.59% |
2022 Q2 | 3.07 Million AUD | 0.0% |
2021 FY | 5 Million AUD | 6095.02% |
2021 Q4 | 5 Million AUD | 0.0% |
2021 Q2 | 2.25 Million AUD | 0.0% |
2020 Q2 | 346.5 Thousand AUD | 0.0% |
2020 Q4 | 80.8 Thousand AUD | 0.0% |
2020 FY | 80.8 Thousand AUD | -87.62% |
2019 FY | 652.74 Thousand AUD | -85.83% |
2019 Q4 | 652.74 Thousand AUD | 0.0% |
2019 Q2 | 2.83 Million AUD | 0.0% |
2018 Q4 | 4.6 Million AUD | 0.0% |
2018 Q2 | 7.08 Million AUD | 0.0% |
2018 FY | 4.6 Million AUD | -6.98% |
2017 Q2 | 7.12 Million AUD | 0.0% |
2017 FY | 4.95 Million AUD | -67.79% |
2017 Q4 | 4.95 Million AUD | 0.0% |
2016 Q4 | 2.92 Million AUD | 0.0% |
2016 FY | 15.37 Million AUD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
4DMedical Limited | 120.01 Million AUD | 89.823% |
Adherium Limited | 9.88 Million AUD | -23.528% |
Aroa Biosurgery Limited | 101.82 Million AUD | 88.005% |
Atomo Diagnostics Limited | 11.37 Million AUD | -7.333% |
Anteris Technologies Ltd | 45.7 Million AUD | 73.276% |
Control Bionics Limited | 9.02 Million AUD | -35.294% |
CardieX Limited | 12.64 Million AUD | 3.45% |
Compumedics Limited | 40.35 Million AUD | 69.737% |
Cochlear Limited | 2.74 Billion AUD | 99.555% |
CleanSpace Holdings Limited | 26.05 Million AUD | 53.119% |
Cyclopharm Limited | 45.91 Million AUD | 73.4% |
EMVision Medical Devices Ltd | 23.97 Million AUD | 49.05% |
Nova Eye Medical Limited | 29.88 Million AUD | 59.128% |
HeraMED Limited | 2.95 Million AUD | -313.72% |
Imricor Medical Systems, Inc. | 12.17 Million AUD | -0.307% |
ImpediMed Limited | 46.98 Million AUD | 74.006% |
InhaleRx Limited | 1.57 Million AUD | -674.527% |
LBT Innovations Limited | 7.93 Million AUD | -53.996% |
Micro-X Limited | 26.89 Million AUD | 54.589% |
OncoSil Medical Limited | 6.71 Million AUD | -81.79% |
PolyNovo Limited | 109.16 Million AUD | 88.812% |
Respiri Limited | 6.19 Million AUD | -97.279% |
SomnoMed Limited | 69.8 Million AUD | 82.503% |
Universal Biosensors, Inc. | 30.12 Million AUD | 59.451% |
Uscom Limited | 5.13 Million AUD | -137.863% |
Visioneering Technologies, Inc. | 11.2 Million AUD | -8.996% |